Basics Tango Therapeutics, Inc. IPO Date: September 3, 2020 Sector: Healthcare Industry: Biotech Market Cap: $275.32M Activated in VL: True Average Daily Range Avg Daily Range: $0.25 | 3.85% Avg Daily Range (30 D): $0.18 | 9.29% Avg Daily Range (90 D): $0.12 | 6.27% Institutional Daily Volume Avg Daily Volume: .62M Avg Daily Volume (30 D): 3.02M Avg Daily Volume (90 D): 1.44M Trade Size Avg Trade Size (Sh.): 115 Avg Trade Size (Sh.) (30 D): 191 Avg Trade Size (Sh.) (90 D): 161 Institutional Trades Total Inst.Trades: 522 Avg Inst. Trade: $1.62M Avg Inst. Trade (30 D): $.75M Avg Inst. Trade (90 D): $1.03M Avg Inst. Trade Volume: .22M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.51M Avg Closing Trade (30 D): $.73M Avg Closing Trade (90 D): $1.45M Avg Closing Volume: 196.57K     News May 27, 2025 @ 11:00 AM Tango Therapeutics to Participate in the 46th Annu... Source: N/A May 12, 2025 @ 11:00 AM Tango Therapeutics Reports First Quarter 2025 Fina... Source: N/A Apr 9, 2025 @ 9:00 AM Barbara Weber, M.D., Elected to ITM Supervisory Bo... Source: N/A Jun 14, 2024 @ 9:10 AM Tango Therapeutics (TNGX) Moves 10.3% Higher: Will... Source: Zacks Equity Research May 24, 2024 @ 3:01 PM Forecasting The Future: 4 Analyst Projections For ... Source: Benzinga Insights Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.21 $-.36 $-.34 Diluted EPS $-1.21 $-.36 $-.34 Revenue $ 40.99M $ 5.39M $ 4.12M Gross Profit $ $ $ Net Income / Loss $ -132.26M $ -39.88M $ -37.67M Operating Income / Loss $ -145.87M $ -42.53M $ -40.91M Cost of Revenue $ $ $ Net Cash Flow $ -2.73M $ -11.1M $ 16.38M PE Ratio